Effects of cilostazol on late lumen loss after Palmaz-Schatz stent implantation

Catheterization and Cardiovascular Diagnosis

Volumn 44, Issue 4, 1998, Pages 387-391

  Yamasaki, Masao ^a   Hara, Kazuhiro ^a   Ikari, Yuji ^a   Kobayashi, Nobuyuki ^a   Kozuma, Ken ^a   Ohmoto, Yuki ^a   Oh Hashi, Yoshio ^a   Ako, Junya ^a   Nakajima, Hiroyoshi ^a   Chiku, Noriyasu ^a   Saeki, Fumihiko ^a   Tamura, Tsutomu ^a  

^a MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Antiplatelet agent; Quantitative coronary angiography; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; GLYCERYL TRINITRATE; HEPARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; FEMALE; HUMAN; IMPLANTATION; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; QUANTITATIVE DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STENT;

AGED; ANIMALS; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DOGS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; STENTS; TETRAZOLES; VASCULAR PATENCY; VASODILATOR AGENTS;

EID: 0031875007     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199808)44:4<387::AID-CCD4>3.0.CO;2-0     Document Type: Article

References (23)

1. Fishman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn IM, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S: A randomized comparison of coronary-stent placement and balloon angioplasty in treatment of coronary artery disease. N Engl J Med 331:496-501, 1994.
2. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Haken E, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M: A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495, 1994.
3. Wong SC, Baim DS, Schatz RA, Teirstein PS, King SB III, Curry, RC Jr, Heuser RR, Ellis SG, Cleman MW, Overlie R, Hirshfeld JW, Walker CM, Litvack F, Fish D, Brinker JA, Buchbinder M, Goldber MB, Chuang YC, Leon M: Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience. J Am Coll Cardiol 26:704-712, 1995.
4. Baim DS, Levine MJ, Leon MB, Levine S, Ellis SG, Schatz RA, for the U.S. Palmaz-Schatz Stent Investigators: Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience). Am J Cardiol 71:364-366, 1993.
5. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M: Serial angiographic follow-up after Palmaz-Schatz stent implantation: Comparison with conventional balloon angioplasty. J Am Coll Cardiol 21:1557-1563, 1993.
6. Umekawa H, Tanaka T, Kimura Y, Hidaka H: Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor Sepharose chromatography. Biochem Pharmacol 33:3339-3344, 1984.
7. Kimura Y, Tani T, Kanbe T, Watanabe K: Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 35:1144-1149, 1985.
8. Takahashi S, Oida K, Fujiwara R, Maeda H, Hayashi S, Takai H, Tamai T, Nakai T, Miyabo S: Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol 20:900-906, 1992.
9. Kubota Y, Kichikawa K, Uchida H, Maeda M, Nishimine K, Makutani S, Sakaguchi S, Yoshioka T, Ohishi H, Kimura Y, Yoshikawa T: Pharmacologic treatment of intimal hyperplasia after metallic stent placement in the peripheral arteries. Invest Radiol 30:532-537, 1995.
10. Ikari Y, Hara K, Tamura T, Saeki F, Yamaguchi T: Luminal loss and site of restenosis after Palmaz-Schatz coronary stent implantation. Am J Cardiol 76:117-120, 1995.
11. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS: Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 21:15-25, 1993.
12. Grodon PC, Gibson M, Cohen DJ, Carrozza JP, Kuntz RE, Baim DS: Mechanisms of restenosis and redilation within coronary stents - Quantitative angiographic assessment. J Am Coll Cardiol 21:1166-1174, 1993.
13. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM: Intravascular stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91:1676-1688, 1995.
14. Houde M, Erbel R, Issa H, Meyer J: Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stent. J Am Coll Cardiol 21:26-34, 1993.
15. Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Salter LF, Popma JJ, Wong SC, Leon MB: Small stent size and intimal hyperplasia contribute to restenosis: A volmetric intravascular ultrasound analysis. J Am Coll Cardiol 26:720-724, 1995.
16. Popma JJ, Sashore TM: Qualitative and quantitative angiography. In Topol EJ (ed): "Textbook of Interventional Cardiology," 2nd ed. Philadelphia: W.B. Saunders Company, 1994, pp 1052-1068.
17. Ellis SG, Savage M, Fishman D: Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 86:1836-1944, 1992.
18. de Jaegere PP, Serruys PW, Bertrand M: Wikter stent implantation in patients with restenosis following balloon angioplasty of a native coronary artery. Am J Cardiol 69:598-602, 1992.
19. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR: Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318:1714-1719, 1988.
20. Taylor RR, Gibbons FA, Cope GD, Cumpston GN, Mews GC, Luke P: Effects of low-dose aspirin on restenosis after coronary angioplasty. Am J Cardiol 68:874-878, 1991.
21. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee KL, Willerson JT, on behalf of the EPIC Investigators: Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 343:881-886, 1994.
22. Schomig A, Neumann F-J, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth E-M, Richardt G, Alt E, Schmitt C, Ulm K: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084-1089, 1996.
23. Reiber JH, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JH, den Boer A, Hugenholtz PG: Assessment of short-, medium-, and long-term variation in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 71:280-288, 1985.